These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 23478140

  • 1. Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK.
    Kostev K, Rathmann W.
    Prim Care Diabetes; 2013 Jul; 7(2):167-71. PubMed ID: 23478140
    [Abstract] [Full Text] [Related]

  • 2. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S, Kostev K, Dippel FW, Giani G, Rathmann W.
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: a retrospective database analysis in Germany and U.K.
    Kostev K, Jockwig A, Hallwachs A, Rathmann W.
    Prim Care Diabetes; 2014 Oct; 8(3):250-5. PubMed ID: 24530101
    [Abstract] [Full Text] [Related]

  • 4. Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices.
    Rathmann W, Kostev K.
    Diabetes Obes Metab; 2013 Apr; 15(4):358-63. PubMed ID: 23137345
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M.
    Ann Acad Med Stetin; 2004 Apr; 50(2):29-39. PubMed ID: 16529163
    [Abstract] [Full Text] [Related]

  • 10. Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.
    Kollhorst B, Behr S, Enders D, Dippel FW, Theobald K, Garbe E.
    Diabetes Obes Metab; 2015 Dec; 17(12):1158-65. PubMed ID: 26279482
    [Abstract] [Full Text] [Related]

  • 11. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.
    Rhoads GG, Kosiborod M, Nesto RW, Fonseca VA, Lu SE, Zhang Q, Foody JM.
    Am J Cardiol; 2009 Oct 01; 104(7):910-6. PubMed ID: 19766755
    [Abstract] [Full Text] [Related]

  • 12. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
    Hall GC, McMahon AD, Carroll D, Home PD.
    Pharmacoepidemiol Drug Saf; 2012 Mar 01; 21(3):305-13. PubMed ID: 22271442
    [Abstract] [Full Text] [Related]

  • 13. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
    Lippmann-Grob B, Bierwirth RA, Kron P, Leinhos B, Funke K, Huptas M, Grüneberg M, Weich KW, Münscher C, Potthoff F.
    Dtsch Med Wochenschr; 2004 Jan 16; 129(3):75-81. PubMed ID: 14724780
    [Abstract] [Full Text] [Related]

  • 14. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL, Richards KM, Lopez D, Cheng LI, Wilson JP.
    Clin Ther; 2011 Dec 16; 33(12):2016-20. PubMed ID: 22101160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
    Grimes RT, Bennett K, Tilson L, Usher C, Smith SM, Henman MC.
    Br J Clin Pharmacol; 2015 Jun 16; 79(6):1000-9. PubMed ID: 25521800
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.